SMNRW
Semnur Pharmaceuticals, Inc.
Price Chart
Latest Quote
$0.13
+0.03 (+29.00%)
Current Price
| Previous Close | $0.10 |
| Open | $0.13 |
| Day High | $0.13 |
| Day Low | $0.13 |
| Volume | 3,000 |
Stock Information
| Total Debt | $19.68M |
| Cash Equivalents | $103K |
| Net Income | $-164.33M |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Income | $-164.33M |
| Book/sh | $-0.11 |
| Employees | 10 |
Financial Ratios
| Quick Ratio | 0.01 |
| Current Ratio | 0.12 |
Returns & Margins
| ROA | -2166.30% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | -1.17 |
Analyst Data
| Recommendation | none |
Technical Indicators
| Shares Float | 29.71M |
Performance History
| YTD | +0.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-10 | $0.13 | 3,000 |
About Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate is SP-102, a novel viscous gel formulation of corticosteroid to treat lumbosacral radicular pain, or sciatica, which is in the second Phase 3 study. The company was founded in 2013 and is headquartered in Palo Alto, California. Semnur Pharmaceuticals, Inc. operates as a subsidiary of Scilex Holding Company.
đ° Latest News
No news articles available at the moment. Check back later for updates on SMNRW.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Revenue | |||
| Total Revenue | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 |
| Expenses | |||
| Total Expenses | $4,690,000 | $3,261,000 | $3,765,000 |
| Operating Expense | $4,690,000 | $3,261,000 | $3,765,000 |
| General And Administrative Expense | $2,981,000 | $1,640,000 | $1,647,000 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| Normalized Income | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| Net Income From Continuing And Discontinued Operation | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| Total Operating Income As Reported | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| Net Income Common Stockholders | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| Net Income | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| Net Income Including Noncontrolling Interests | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| Net Income Continuous Operations | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| Pretax Income | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| Operating Income | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| EBITDA (Bullshit earnings) | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| EBIT | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| Diluted NI Availto Com Stockholders | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| Research And Development | $1,709,000 | $1,621,000 | $2,118,000 |
| Selling General And Administration | $2,981,000 | $1,640,000 | $1,647,000 |
| Other Gand A | $2,981,000 | $1,640,000 | $1,647,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $-42,784,000 | $-38,094,000 | $-34,833,000 |
| Total Assets | $6,684,000 | $703,000 | $762,000 |
| Total Non Current Assets | $689,000 | $689,000 | $689,000 |
| Current Assets | $5,995,000 | $14,000 | $73,000 |
| Other Current Assets | $5,981,000 | - | - |
| Prepaid Assets | $2,000 | $2,000 | $45,000 |
| Cash Cash Equivalents And Short Term Investments | $12,000 | $12,000 | $28,000 |
| Cash And Cash Equivalents | $12,000 | $12,000 | $28,000 |
| Debt | |||
| Net Debt | $49,421,000 | $37,889,000 | $35,372,000 |
| Total Debt | $49,433,000 | $37,901,000 | $35,400,000 |
| Long Term Debt And Capital Lease Obligation | $49,433,000 | $37,901,000 | $35,400,000 |
| Long Term Debt | $49,433,000 | $37,901,000 | $35,400,000 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $49,468,000 | $38,797,000 | $35,595,000 |
| Total Non Current Liabilities Net Minority Interest | $49,433,000 | $37,901,000 | $35,400,000 |
| Current Liabilities | $35,000 | $896,000 | $195,000 |
| Payables And Accrued Expenses | $35,000 | $896,000 | $195,000 |
| Equity | |||
| Common Stock Equity | $-42,784,000 | $-38,094,000 | $-34,833,000 |
| Total Equity Gross Minority Interest | $-42,784,000 | $-38,094,000 | $-34,833,000 |
| Stockholders Equity | $-42,784,000 | $-38,094,000 | $-34,833,000 |
| Retained Earnings | $-115,384,000 | $-110,694,000 | $-107,433,000 |
| Other | |||
| Ordinary Shares Number | $240,082,286 | $240,082,286 | $240,082,286 |
| Share Issued | $240,082,286 | $240,082,286 | $240,082,286 |
| Tangible Book Value | $-42,784,000 | $-38,094,000 | $-34,833,000 |
| Invested Capital | $6,649,000 | $-193,000 | $567,000 |
| Working Capital | $5,960,000 | $-882,000 | $-122,000 |
| Total Capitalization | $6,649,000 | $-193,000 | $567,000 |
| Additional Paid In Capital | $72,598,000 | $72,598,000 | $72,598,000 |
| Capital Stock | $2,000 | $2,000 | $2,000 |
| Common Stock | $2,000 | $2,000 | $2,000 |
| Preferred Stock | $0 | $0 | - |
| Current Accrued Expenses | $35,000 | $896,000 | $195,000 |
| Net PPE | $689,000 | $689,000 | $689,000 |
| Accumulated Depreciation | $-25,000 | $-25,000 | $-25,000 |
| Gross PPE | $714,000 | $714,000 | $714,000 |
| Construction In Progress | $689,000 | $689,000 | $689,000 |
| Machinery Furniture Equipment | $25,000 | $25,000 | $25,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-4,891,000 | $-1,677,000 | $-4,043,000 |
| Operating Activities | |||
| Operating Cash Flow | $-4,891,000 | $-1,677,000 | $-4,043,000 |
| Cash Flow From Continuing Operating Activities | $-4,891,000 | $-1,677,000 | $-4,043,000 |
| Financing Activities | |||
| Financing Cash Flow | $4,891,000 | $1,661,000 | $3,974,000 |
| Cash Flow From Continuing Financing Activities | $4,891,000 | $1,661,000 | $3,974,000 |
| Net Other Financing Charges | $-5,981,000 | - | - |
| Other | |||
| Issuance Of Debt | $10,872,000 | $1,661,000 | $3,974,000 |
| End Cash Position | $12,000 | $12,000 | $28,000 |
| Beginning Cash Position | $12,000 | $28,000 | $97,000 |
| Net Issuance Payments Of Debt | $10,872,000 | $1,661,000 | $3,974,000 |
| Net Long Term Debt Issuance | $10,872,000 | $1,661,000 | $3,974,000 |
| Long Term Debt Issuance | $10,872,000 | $1,661,000 | $3,974,000 |
| Change In Working Capital | $-861,000 | $744,000 | $-1,150,000 |
| Change In Payables And Accrued Expense | $-861,000 | $701,000 | $-1,340,000 |
| Change In Accrued Expense | $-861,000 | $701,000 | $-563,000 |
| Change In Prepaid Assets | $0 | $43,000 | $190,000 |
| Stock Based Compensation | $660,000 | $840,000 | $872,000 |
| Net Income From Continuing Operations | $-4,690,000 | $-3,261,000 | $-3,765,000 |
| Changes In Cash | - | $-16,000 | $-69,000 |
| Change In Account Payable | - | $0 | $-777,000 |
| Change In Payable | - | - | $-777,000 |
Fetched: 2026-02-02